Literature DB >> 9201306

Differential role for IL-2 and IL-15 in the inhibition of apoptosis in short-term activated human lymphocytes.

H M Lorenz1, T Hieronymus, M Grünke, B Manger, J R Kalden.   

Abstract

Interleukin (IL)-15 is a newly described cytokine with properties similar to IL-2. Even though it does not share sequence homology with IL-2, both cytokines bind to the same receptor with the noted exception of a cytokine specific alpha-chain. In this study the authors compared IL-2 and IL-15 to determine their ability to rescue short term activated lymphocytes (phytohaemagglutinin stimulation of peripheral blood mononuclear cells for 6 days, followed by expansion in medium containing IL-2 for 2 days) from apoptotic cell death. The authors found that both IL-2 and IL-15 can inhibit induction of apoptosis in this experimental model with similar time and dose kinetics. On mRNA or protein levels induction of pro- and anti-apoptotic gene products like fasL, bcl-2, or bax with minor effects on fas/Apo-1 or bcl-XL was observed under culture conditions with both IL-2 and IL-15. Next, it was found that phytohaemagglutinin (PHA) blasts were less responsive (in terms of cellular proliferation and prevention from apoptosis) to IL-2 if signals through the alpha-chain were blocked, with no effect on beta-chain specific monoclonal antibodies (MoAb). By contrast, IL-15 was less effective in induction of cellular proliferation and prevention of apoptosis if IL-2R beta-chain specific MoAb were added to cell cultures. Testing intracellular signalling induced by IL-2 or IL-15, the authors found identical changes in tyrosine phosphorylation patterns in PHA blasts cultured in medium or under IL-2 or IL-15 stimulation. By contrast, they found consistent differences if PHA stimulated peripheral blood mononuclear cells (PBMC) were expanded in medium containing IL-15 (instead of IL-2). These IL-15 expanded PHA blasts showed a significantly increased percentage of apoptosis after growth factor withdrawal. Furthermore, IL-2 was more efficient than IL-15 in rescuing IL-15 expanded PHA blasts from apoptosis. In IL-15 expanded PHA blasts expression of IL-2R alpha-chain was lower than that in IL-2 expanded PHA blasts. A model presenting a differential role for IL-2 and IL-15 in inhibition of apoptosis in vivo is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9201306     DOI: 10.1046/j.1365-3083.1997.d01-443.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  7 in total

1.  Serum level of sFas in patients with Wegener's granulomatosis.

Authors:  Eugene J Kucharz; Anna T Kotulska; Przemyslaw J Kotyla; Magdalena M Kopeć; Bogdan Krupnik; Robert Pieczyrak
Journal:  Clin Rheumatol       Date:  2005-07-15       Impact factor: 2.980

2.  Activation, survival and apoptosis of CD45RO+ and CD45RO- T cells of human immunodeficiency virus-infected individuals: effects of interleukin-15 and comparison with interleukin-2.

Authors:  H Naora; M Gougeon
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

3.  Expression of the activation antigen CD69 predicts functionality of in vitro expanded peripheral blood mononuclear cells (PBMC) from healthy donors and HIV-infected patients.

Authors:  S D Nielsen; P Afzelius; A K Ersbøll; J O Nielsen; J E Hansen
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

Review 4.  Systemic lupus erythematosus and apoptosis: a question of balance.

Authors:  Dror Mevorach
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

5.  gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells.

Authors:  L S Kierstead; E Ranieri; W Olson; V Brusic; J Sidney; A Sette; Y L Kasamon; C L Slingluff; J M Kirkwood; W J Storkus
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640

6.  Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins.

Authors:  G Pirtskhalaishvili; G V Shurin; C Esche; Q Cai; R R Salup; S N Bykovskaia; M T Lotze; M R Shurin
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

7.  Tissue maintenance of CMV-specific inflationary memory T cells by IL-15.

Authors:  Nicolas S Baumann; Nicole Torti; Suzanne P M Welten; Isabel Barnstorf; Mariana Borsa; Katharina Pallmer; Jennifer D Oduro; Luka Cicin-Sain; Koichi Ikuta; Burkhard Ludewig; Annette Oxenius
Journal:  PLoS Pathog       Date:  2018-04-13       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.